Navigation Links
AXIMA-CFR MALDI TOF from Shimadzu Biotech

ProductsAXIMA-CFR MALDI TOF from Shimadzu Biotech
Company Shimadzu Biotech
Item AXIMA-CFR MALDI TOF
Price 
Description The standard of the Axima range, the AXIMA-CFR provides a combination of high mass accuracy, resolution, sensitivity and mass range, and offers excellent versatility with both linear and reflectron time-of-flight analysis. The unique patented curved field reflectron enables the generation of seamless PSD, providing efficient and economical peptide fragmentation data for protein identification. Data can be acquired just as easily for large peptides (up to 3500 Da) as for small ones. Powerful LAUNCHPAD software features many unique functions for proteomics and enables access to protein databases for sequence searching without the need for de novo sequencing or creation of sequence tags.
Info Shimadzu BiotechShimadzu Biotech
Japan/Asia
Shimadzu Corporation
1 Nishinokyo Kuwabaracho
Nakagyoku, Kyoto 604-8511
Japan
Phone: +81-75-823-1148
Fax: +81-75-823-1364
info@shimadzu-biotech.net

United States
Shimadzu Biotech USA
7102 Riverwood Drive
Columbia, Maryland 21046 USA
Phone: 800-477-1227/410-381-1227
info@shimadzu-biotech.net

England
Shimadzu Biotech
Wharfside
Trafford Wharf Road
Manchester
M17 1GP
England
Tel +44 161 888 4414
Fax +44 161 888 4402
MALDI
chris.sutton@kratos.co.uk
LCMS
nl@shimadzu.de

For contacts in other regions
please click here.

Customer Service: see above
Fax Number: see above
Web Site: http://www.shimadzu-biotech.net
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. AXIMA-CFRplus MALDI TOF from Shimadzu Biotech
2. AccuSpot LC-MALDI Plate Spotter from Shimadzu
3. Protein Identification Service via MALDI MS/MS from Protagen AG
4. PDF-MALDI Source from Agilent Technologies
5. Mass Spectrometry Service using MALDI-TOF/TOF from Applied Biomics, Inc.
6. prOTOF 2000 MALDI O-TOF Mass Spectrometer from PerkinElmer
7. AXIMA-LNR Linear MALDI TOF from Shimadzu Biotech
8. ProteoMass Apomyoglobin MALDI-MS Standard from Sigma-Aldrich
9. ProteoMass Cytochrome c MALDI-MS Standard from Sigma-Aldrich
10. ProteoMass Angiotensin II MALDI-MS Standard from Sigma-Aldrich
11. LCMS-IT-TOF Formula Predictor System from Shimadzu
Acetyl-Histone H3 Immunoprecipitation (ChIP) Assay Kit from Upstate
... Ribonuclease III (RNase III) from E. coli is an e...tranded RNA (dsRNA) to dsRNA fragments that have 2...results in dsRNA fragments of 12-15 bp. RNase III...cal ribonucleotides as well as DuraScript™ RN...
Mouse Anti-E. coli K99 pilus Monoclonal Antibody, Unconjugated, Clone 6911 from Abcam
TopSpot E non-contact microarrayer from Parallabs
Biology Products:
(Date:12/3/2009)...ve that staph infections are caused by many bacter...he signaling process is called quorum sensing beca...cess. , But the Jeff Brinker research group has ...ction, when bacteria switch from a harmless to a v...s individual process can be stopped by the applica...
(Date:12/3/2009)...vels for the past three years in the troposphere (...area near Valladolid. The results, which are the f...that the levels rose "significantly" between 2002 ...teorologists have been trying to find out about ca...ved in the troposphere over various urban and rura...
(Date:12/2/2009)... men have a more difficult time quitting smoking t...e, but acculturation has no affect on Latinas odds...e published in Cancer Epidemiology, Biomarkers & ... for Cancer Research. The December issue has a spe...smoking cessation differently for Latino men and w...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Acculturation affects smoking cessation success among Latinos 2National Greatness Contest Winners Announced 58136 1National Greatness Contest Winners Announced 58136 2National Greatness Contest Winners Announced 58136 3Morphotek 28R 29 Inc Awarded Funding to Develop Therapeutic Antibodies Against Potential Biowarfare Toxins 14231 1Morphotek 28R 29 Inc Awarded Funding to Develop Therapeutic Antibodies Against Potential Biowarfare Toxins 14231 2Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 1Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 2Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 3
... at Case Western Reserve University have developed...cer-fighting drugs to diseased areas within hours,... existing delivery systems. , Using laboratory mic... cells was reduced from two days to mere hours. Us...r patients may someday soon receive the benefits o...
...ion of biological data today is a significant chal... some scientists to focus on new ways to better ma...The laboratory of Bruce Conklin in the Gladstone I...ew collaboration tool, WikiPathways to focus on th...athways connect genes and proteins in systems that...
...ilable in Spanish . , , Plants undergo stress ...old or to excess of light. A research team from th...he substances that are triggered in plants to prot...ies that is best suited to the environment during ...ns. , Droughts, extreme temperatures, contaminati...
Other Biology News:Cancer drug delivery research at Case Western Reserve University cuts time from days to hours 2Cancer drug delivery research at Case Western Reserve University cuts time from days to hours 3Gladstone scientists create Wikipathways to foster research collaboration 2Measuring the stress of forested areas 2Measuring the stress of forested areas 3
(Date:12/2/2009)...RNewswire-FirstCall/ - AEterna Zentaris Inc. (NASD...opharmaceutical company focused on endocrine thera...d and Drug Administration (FDA) has granted Fast T...y inhibitor compound, perifosine (KRX-0401), for t...ma. Keryx Biopharmaceuticals, Inc. ("Keryx") ( KER...
(Date:12/2/2009)... According to the National Institu...s diagnosed with diabetes already have some stage ...mage to the retina caused by leaky blood vessels, ...tes and is one of the most feared diabetic complic... who,ve had diabetes for 10 years or more will exp...
(Date:12/1/2009)... Reportlinker.com announces that a...talogue: ,, Chromium - Global Market Trends ...ium---Global-Market-Trends.html ,, Worldwide d...nless steel, while growth in aerospace and industr...th of chromium metal. Environmental constraints an...
(Date:12/1/2009)...1 Harvest Technologies Corp. ( www...e company sponsored 60-patient clinical trial cond..., India using the company,s BMAC System to treat p...hemia (CLI). Sri Ramachandra Medical Center is a H...n based in Chennai, India and one of the largest p...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3